Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ZYDUS PHARMS USA

  • FDA Approval
  • Feb. 20, 2025, 09:43 UTC
  • 17

FDA approve PRAVASTATIN SODIUM

Comment Full text

GILEAD SCIENCES INC

  • FDA Approval
  • Feb. 20, 2025, 09:43 UTC
  • 20

FDA approve EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Feb. 20, 2025, 09:43 UTC
  • 14

FDA approve DULOXETINE HYDROCHLORIDE

Comment Full text

NOVEL LABS INC

  • FDA Approval
  • Feb. 20, 2025, 09:43 UTC
  • 16

FDA approve NITROFURANTOIN, MACROCRYSTALLINE

Comment Full text

HIKMA

  • FDA Approval
  • Feb. 20, 2025, 09:43 UTC
  • 16

FDA approve FLUCYTOSINE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Feb. 20, 2025, 09:43 UTC
  • 17

FDA approve BIVALIRUDIN

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • Feb. 20, 2025, 05:53 UTC
  • 17

FDA approve AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Comment Full text

MSN

  • FDA Approval
  • Feb. 20, 2025, 05:53 UTC
  • 21

FDA approve SUNITINIB MALATE

Comment Full text

HIKMA

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 21

FDA approve NAPROXEN

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 20

FDA approve ATROPINE SULFATE

Comment Full text
  • Previous
  • 50
  • 51
  • 52
  • 53
  • 54
  • Next

Search

News categories

  • Technical Exchange News(9109)
  • Event(407)
  • SEC News(145256)
  • FDA Approval(8448)
  • Company Report(721)
  • Business News(101100)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin